Cargando…
Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMP
Previously, we have demonstrated that progesterone and calcitriol synergistically inhibit growth of endometrial and ovarian cancer by enhancing apoptosis and causing cell cycle arrest. Metastasis is the main reason of mortality in cancer patients. Activation of ADP-Ribosylation Factor 6 (ARF6), Neur...
Autores principales: | Waheed, Sana, Dorjbal, Batsukh, Hamilton, Chad A., Maxwell, G. Larry, Rodriguez, Gustavo C., Syed, Viqar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768348/ https://www.ncbi.nlm.nih.gov/pubmed/29371931 http://dx.doi.org/10.18632/oncotarget.22745 |
Ejemplares similares
-
Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1
por: Bokhari, Amber A., et al.
Publicado: (2016) -
Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro
por: Paucarmayta, Ana, et al.
Publicado: (2020) -
Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathway
por: Bokhari, Amber A., et al.
Publicado: (2016) -
TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types
por: Paucarmayta, Ana, et al.
Publicado: (2019) -
Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A
por: Waheed, Sana, et al.
Publicado: (2019)